Dr. Ahmad Tarhini, MD – Tampa, FL
Sarah Scott Overview of Dr. Tarhini
Dr. Ahmad Tarhini is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Kaunas Medical Institute and has been in practice 23 years. Dr. Tarhini accepts several types of health insurance, listed below. He is one of 171 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2003 - 2006
UPMC Medical EducationResidency, Internal Medicine, 2000 - 2003
Kaunas Medical InstituteClass of 1999
Certifications & Licensure
FL State Medical License 2019 - 2025
GA State Medical License 2018 - 2020
OH State Medical License 2017 - 2019
PA State Medical License 2001 - 2018
Clinical Trials
Publications & Presentations
PubMed
Comparing the rate of immunotherapy treatment change due to toxicity by sex.
Chua, K., Liu, H., Schneider, B., Sterling, J., Singer, E., Kronstedt, S., Kaldany, A., Srivastava, A., Tarhini, A., Gatti-Mays, M., Gaughan, E., Hu-Lieskovan, S., Alj...> ;Cancer Reports. 2024 Jan 8The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhib...
Islam Eljilany, Payman Ghasemi Saghand, James Chen, Aakrosh Ratan, Martin McCarter, John Carpten, Howard Colman, Alexandra P Ikeguchi, Igor Puzanov, Susanne Arnold, Mi...> ;Cancers. 2023 Oct 10Translation of AI into oncology clinical practice.
Issam El Naqa, Aleksandra Karolak, Yi Luo, Les Folio, Ahmad A Tarhini, Dana Rollison, Katia Parodi> ;Oncogene. 2023 Oct 1- Join now to see all
Journal Articles
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced Melanoma
Igor Puzanov, Kim A Margolin, Jose Lutzky, Ahmad Tarhini, Nageatte Ibrahim, JAMA OncologyCombined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Kim Margolin, Omid Hamid, Christopher D Lao, Anna C Pavlick, Michael A Postow, F Stephen Hodi, Nikhil I Khushalani, Marc S Ernstoff, Hussein A Tawbi, Igor Puzanov, Ahm..., The New England Journal of Medicine
Lectures
United States Intergroup E1609: A phase III randomized study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon-α2b for resected high-risk melanoma.
2019 ASCO Annual Meeting - 6/1/2019Clinical and economic outcomes associated with sequential treatment in BRAF mutant advanced melanoma patients.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018Association of Community Cancer Centers(ACCC) 30th National Conference
Association of Community Cancer Centers (ACCC), Boston, Massachusetts - 10/2/2013- Join now to see all
Authored Content
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaJuly 2020
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaJuly 2020
Press Mentions
Covid-19 Two Years on: Persistent Symptoms of Clinical Trial Disruption Trouble Certain Therapy AreasMarch 31st, 2022
The Opdualag Effect: Designing First-Line Melanoma Clinical Trials After Anti-LAG-3 Antibody ApprovalMarch 23rd, 2022
Advanced Melanoma Survival and Costs Differ in Treatment Combo and Sequence ComparisonJune 4th, 2018
- Join now to see all
Professional Memberships
Hospital Affiliations
Insurance Accepted
Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Oklahoma
First Choice
First Health PPO
Great West PPOHealth Net Oregon PPO
HealthAmerica HealthAssurance PPO
Highmark BCBS ClassicBlue
Highmark BCBS PPOBlue
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
ODS Network
Providence Health System Personal Option
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO- Please verify your coverage with the provider's office directly when scheduling an appointment